Skip to content

Exercise trial reports symptom improvements in systemic sclerosis

Combined supervised exercise outperformed usual care on reported symptoms, but unclear score scales and an inconsistent confidence interval limit interpretation.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Participants assigned to supervised combined exercise reported improvements in pain and fatigue compared with those receiving usual care alone. This supports a possible role for the studied program in this specific patient group. The abstract does not make the size of the symptom changes clear enough to judge how noticeable they were.

Keep in mind

The fatigue confidence interval is internally inconsistent as printed, and the pain and fatigue score scales are unnamed. Although later assessment was planned, the abstract only reports results at the primary endpoint.

THE RESULT, WITH CONTEXT

What researchers found

Statistically significant improvement

Pain and fatigue scores

Exercise plus usual care versus usual care alone at 12 weeks; numerical effects are omitted because their scales and the fatigue interval are unclear.

RMD Open, 2025 · Original source ↓

Combined program

The program combined supervised interval exercise with resistance training. Because participants received both components together, the trial does not isolate their separate effects or establish whether another intensity or exercise format would work similarly.

Scope of findings

Reported improvements also included depression, quality of life, self-reported function, strength, endurance and fitness. Most participants had the limited cutaneous disease form, which narrows how broadly the findings can be applied across systemic sclerosis.

CHECK THE ORIGINAL

The original publication

High-intensity interval and resistance training programme improves pain and fatigue outcomes in people with systemic sclerosis: a European multicentre randomised controlled trial.

Mitropoulos A, Jensen KY, Kouidi E et al.
RMD Open · 2025

PubMed ID
41219127
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.